abstract |
The presented invention relates to compounds of formula (Ia) or their pharmaceutically acceptable salts, where Q, G, ring A, R, R, R, R, R, R, R, R, R, R, R, R, R, R, R, R, R and n, p are defined herein. New purine derivatives are acceptable in the treatment of abnormal cell growth, such as cancer, in mammals. |